- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Larimar Therapeutics Inc (LRMR)
Assess today's live Larimar Therapeutics Inc (LRMR) share price, performance and insights using our live NASDAQ: LRMR stock exchange data.
Analyse the historical data and Larimar Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Larimar Therapeutics Inc share price buy/sell indicators using real-time data (or discuss the Larimar Therapeutics Inc (LRMR) stock price today with other investors in the Larimar Therapeutics Inc NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LRMR share price (ISIN: US5171251003) to enhance your trading decisions with our free investment tools and resources.
What Is the Larimar Therapeutics Inc Share Price Today?
The Larimar Therapeutics Inc share price today is 3.330.
What Is the Stock Symbol for Larimar Therapeutics Inc
The stock symbol (or 'ticker') for Larimar Therapeutics Inc is "LRMR."
What Stock Exchange Does Larimar Therapeutics Inc Trade On?
Larimar Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Larimar Therapeutics Inc a Good Stock to Buy?
Determining whether Larimar Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Larimar Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Larimar Therapeutics Inc share price buy/sell indicators using real-time data (or discuss the Larimar Therapeutics Inc (LRMR) stock price today with other investors in the Larimar Therapeutics Inc NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ LRMR share price (ISIN: US5171251003) to enhance your trading decisions with our free investment tools and resources.
What Is the Larimar Therapeutics Inc Share Price Today?
The Larimar Therapeutics Inc share price today is 3.330.
What Is the Stock Symbol for Larimar Therapeutics Inc
The stock symbol (or 'ticker') for Larimar Therapeutics Inc is "LRMR."
What Stock Exchange Does Larimar Therapeutics Inc Trade On?
Larimar Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Larimar Therapeutics Inc a Good Stock to Buy?
Determining whether Larimar Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.305
3.480
52 wk Range
1.610
5.370
LRMR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.3053.480
52 wk Range
1.6105.370
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LRMR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
14.667
Upside
+340.44%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Larimar Therapeutics Inc For: 17 December
- Investing.com
- Form 8K Larimar Therapeutics Inc For: 12 January
- Investing.com
- Form 8K Larimar Therapeutics Inc For: 12 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Larimar Therapeutics Inc Company Profile
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich’s ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Larimar Therapeutics Inc SWOT Analysis
Nomlabofusp Promise | Larimar's lead drug candidate shows potential to address the root cause of Friedreich's ataxia, positioning the company at the forefront of FA treatment research |
Clinical Milestones | Explore Larimar's progress in adult and pediatric trials, with key data releases expected to serve as potential catalysts for stock performance |
Regulatory Landscape | Learn about Larimar's strategy for accelerated approval and how potential FDA easements for rare diseases could impact the company's timeline |
Market Dynamics | Delve into Larimar's positioning in the evolving FA treatment market, with analyst price targets ranging from $10 to $40 despite recent stock volatility |
Compare LRMR to Peers and Sector
Metrics to compare | LRMR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLRMRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.2x | −5.2x | −0.5x | |
PEG Ratio | 0.03 | −0.15 | 0.00 | |
Price/Book | 2.0x | 5.5x | 2.6x | |
Price / LTM Sales | - | 6,069.9x | 3.3x | |
Upside (Analyst Target) | 254.5% | 67.9% | 45.0% | |
Fair Value Upside | Unlock | −15.4% | 5.1% | Unlock |
Analyst Ratings
10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.667
(+340.44% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
-0.61 / -0.4128
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Larimar Therapeutics Inc (LRMR) Share Price Today?
The live Larimar Therapeutics Inc share price today is 3.330
What Stock Exchange Does Larimar Therapeutics Inc (LRMR) Trade On?
Larimar Therapeutics Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Larimar Therapeutics Inc?
The stock symbol (also called a 'ticker') for Larimar Therapeutics Inc is "LRMR."
What Is the Current Larimar Therapeutics Inc Market Cap?
As of today, Larimar Therapeutics Inc market capitalisation is 287.16M.
What Is Larimar Therapeutics Inc's (LRMR) Earnings Per Share (TTM)?
The Larimar Therapeutics Inc EPS is currently -1.95 (Trailing Twelve Months).
When Is the Next Larimar Therapeutics Inc Earnings Date?
Larimar Therapeutics Inc's next earnings report will be released on 18 Mar 2026.
Is LRMR a Buy or Sell From a Technical Analyst Perspective?
Based on today's Larimar Therapeutics Inc moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Larimar Therapeutics Inc Stock Split?
Larimar Therapeutics Inc has split 1 times. (See the LRMR stock split history page for full effective split date and price information.)
How Many Employees Does Larimar Therapeutics Inc Have?
Larimar Therapeutics Inc has 65 employees.
What is the current trading status of Larimar Therapeutics Inc (LRMR)?
As of 11 Feb 2026, Larimar Therapeutics Inc (LRMR) is trading at a price of 3.330, with a previous close of 3.390. The stock has fluctuated within a day range of 3.305 to 3.480, while its 52-week range spans from 1.610 to 5.370.
What Is Larimar Therapeutics Inc (LRMR) Price Target According to Analysts?
The average 12-month price target for Larimar Therapeutics Inc is USD14.667, with a high estimate of USD26 and a low estimate of USD7. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +340.44% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.